Vaccine Responses in Cancer

Enrolling By Invitation
99 years and younger
All
Phase N/A
1 Location

Brief description of study

Adults with a cancer diagnosis who need to receive vaccination as part of standard-of-care will be vaccinated in this study accompanied by four peripheral venipuncture events on days 0, 7, 28, and 90 (visits 1-4) following vaccination. If patients are vaccinated more than two times within the same season, subjects have the option to collect blood draw sets (Visits 1-4) separately if the vaccines have been administered more than 28 days apart from each other.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: - 99 Years
  • Gender: All

TBD

Updated on 01 Aug 2024. Study ID: 852151
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research